Global cancer statistics, 2012
Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet-Tieulent,Ahmedin Jemal +5 more
Reads0
Chats0
TLDR
A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.Abstract:
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.read more
Citations
More filters
Journal ArticleDOI
Candidate miRNAs in human breast cancer biomarkers: a systematic review
TL;DR: Although these miRNAs require being validated and further investigated, they could be potential candidates for BC miRNA biomarkers and used for early prognosis or diagnosis.
Journal ArticleDOI
Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer.
Ming-Ming Wei,Guang-Biao Zhou +1 more
TL;DR: This review highlights the expression and roles of lncRNAs in NSCLC and discusses their potential clinical applications as diagnostic or prognostic biomarkers, as well as therapeutic targets.
Journal ArticleDOI
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
Yusuke Inoue,Katsuhiro Yoshimura,Kazutaka Mori,Nobuya Kurabe,Tomoaki Kahyo,Hiroki Mori,Akikazu Kawase,Masayuki Tanahashi,Hiroshi Ogawa,Naoki Inui,Kazuhito Funai,Kazuya Shinmura,Hiroshi Niwa,Takafumi Suda,Haruhiko Sugimura +14 more
TL;DR: It is concluded that an increase in PD-L 1 gene copy number can be a feasible alternative biomarker for predicting response to anti-PD-1/PD-L1 therapy.
Journal ArticleDOI
Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions
TL;DR: There is some evidence that PHI outperforms PCA3 in predicting significant PCa in an active surveillance population, and future research should focus on independent validation of promising fluid-based biomarkers/models, and prospective comparison of biomarkers with each other.
Journal ArticleDOI
Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry.
Gholamreza Roshandel,Ali Ghanbari-Motlagh,Elham Partovipour,Fereshteh Salavati,Susan Hasanpour-Heidari,Gohar Mohammadi,Mostafa Khoshaabi,Alireza Sadjadi,Masoud Davanlou,Seyed Mohammad Tavangar,Hakimeh Abadi,Abasali Asgari,Mohamadreza Behrooz,Maria Cheraghi,Leila Danechin,Roya Dolatkhah,Floria Enferadi,soodabeh Esshaghi,Mohsen Farmahini Farahani,Solmaz Farrokhzad,Mansooreh Fateh,Siamak Vahedi,Arash Golpazir,Mahdieh Hasanzadeh,Narjes Hazar,Hosein Hoseini-hoshyar,Mohsen Izadi,Ali Jafarnia,Mahdi Jahantigh,Ahmad Jalilvand,Mehrdad Jazayeri,Parvin Joola,Yasan Kazemzadeh,Maryam Khalednejad,Maryam Kooshki,Amineh Madani,Reza Malekpour-Afshar,Amir-Hossein Bayat,Zeinab Moinfar,Hosein Mohamadifar,Gholamhasan Mohamadzadeh,Rita Motidost-komleh,Mahboobeh Narooei,Sharareh Niksiar,Habibollah Pirnejad,Azadeh Poornajaf,Gita Pourshahi,Amir Rahnama,Bahman Rashidpour,Zahra Ravankhah,Khadijeh Rezaei,Abbas Rezaeianzadeh,Gholamreza Sadeghi,Athar Shahdadi,Mehraban Shahi,Zahra Sharafi,Farroq Sharifi-moghadam,Ali Soleimani,Maryam Soltany-hojatabad,Zeinab Tahmasebi,Sohrab Yadolahi,Majid Yaghoubi-ashrafi,Hamed Zandian,Aliakbar Zareiyan,Hossein Poustchi,Kazem Zendehdel,Afshin Ostovar,Ghasem Janbabaei,Alireza Reisi,Reza Malekzadeh +69 more
TL;DR: The results showed that Iran is a medium-risk area for incidence of cancers, and differences in the most common cancers in Iran comparing to those reported for the World.
References
More filters
Journal ArticleDOI
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Souto Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray +8 more
TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Journal ArticleDOI
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book
Cancer Incidence in Five Continents
Freddie Bray,J. Ferlay,Mathieu Laversanne,David H. Brewster,C. Gombe Mbalawa,B. Kohler,Marion Piñeros,Eva Steliarova-Foucher,Rajaraman Swaminathan,Sebastien Antoni,Isabelle Soerjomataram,David Forman +11 more
TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.